Surgery Partners’ (SGRY) Buy Rating Reaffirmed at Citigroup Inc.
Surgery Partners, Inc. (NASDAQ:SGRY)‘s stock had its “buy” rating restated by analysts at Citigroup Inc. in a research report issued on Friday. They presently have a $17.00 target price on the stock, down from their prior target price of $28.00. Citigroup Inc.’s price target indicates a potential upside of 53.15% from the company’s previous close.
SGRY has been the subject of several other research reports. BidaskClub lowered shares of Surgery Partners from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, May 10th. Stifel Nicolaus lowered their price target on shares of Surgery Partners from $19.00 to $18.00 and set a “hold” rating for the company in a report on Monday, April 24th. Finally, Raymond James Financial, Inc. restated a “market perform” rating on shares of Surgery Partners in a report on Wednesday, August 9th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $20.67.
Shares of Surgery Partners (SGRY) traded down 2.928% on Friday, reaching $10.775. 57,648 shares of the company traded hands. The stock has a market cap of $525.94 million, a price-to-earnings ratio of 70.888 and a beta of 1.71. Surgery Partners has a 52-week low of $9.20 and a 52-week high of $24.05. The stock has a 50 day moving average of $20.32 and a 200 day moving average of $20.21.
COPYRIGHT VIOLATION NOTICE: “Surgery Partners’ (SGRY) Buy Rating Reaffirmed at Citigroup Inc.” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/08/11/citigroup-inc-lowers-surgery-partners-inc-nasdaqsgry-price-target-to-17-00.html.
Hedge funds have recently added to or reduced their stakes in the stock. Bank of Montreal Can bought a new stake in Surgery Partners during the first quarter valued at $120,000. Atria Investments LLC bought a new stake in Surgery Partners during the first quarter valued at $203,000. Voya Investment Management LLC bought a new stake in Surgery Partners during the second quarter valued at $222,000. American International Group Inc. raised its stake in Surgery Partners by 7.1% in the first quarter. American International Group Inc. now owns 11,462 shares of the company’s stock valued at $224,000 after buying an additional 759 shares in the last quarter. Finally, Campbell Newman Asset Management Inc. bought a new stake in Surgery Partners during the first quarter valued at $235,000. Institutional investors own 38.42% of the company’s stock.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.